Simmons & Simmons advised Eisai on the divestment. Eisai S.A.S, the French subsidiary of Eisai Co., Ltd., has transferred its rights to Loxapac (loxapine) and Parkinane...
CNX Therapeutics’ €56.5m Acquisition of Eisai’s Rights in Loxapac and Parkinane
Genoscience Pharma’s Licence Agreement with Genfit
IN BRIEF: Simmons & Simmons, advised on the matter. Simmons & Simmons advised Genoscience Pharma Inc. with a team including Alexandre Regniault (Picture – Life Science...